celiprolol has been researched along with Hyperlipemia in 7 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of celiprolol on insulin sensitivity, glucose tolerance and serum lipids were compared to those of other antihypertensive drugs (beta- or Ca-blocker or ACE-inhibitor) in 23 dyslipidemic non-diabetic patients with controlled hypertension." | 9.08 | Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension. ( Huupponen, R; Lahtela, JT; Malminiemi, K, 1995) |
| "The effects of a vasodilating beta-blocker, celiprolol, on insulin sensitivity and cardiovascular risk factors were compared with those of another beta1-selective adrenoceptor blocker, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors." | 9.08 | Insulin sensitivity in a long-term crossover trial with celiprolol and other antihypertensive agents. ( Ala-Kaila, K; Huupponen, R; Lahtela, J; Malminiemi, K; Malminiemi, O, 1998) |
| "The effects of celiprolol on insulin sensitivity, glucose tolerance and serum lipids were compared to those of other antihypertensive drugs (beta- or Ca-blocker or ACE-inhibitor) in 23 dyslipidemic non-diabetic patients with controlled hypertension." | 5.08 | Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension. ( Huupponen, R; Lahtela, JT; Malminiemi, K, 1995) |
| "The effects of celiprolol 200 mg or 400 mg once daily on blood pressure (BP), serum lipids, plasma fibrinogen and airways function was compared with the effects of metoprolol 100 mg or 200 mg once daily in 171 patients with mild to moderate hypertension and coexistent hyperlipidaemia in a double-blind, multicentre study lasting 1 year." | 5.08 | Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial. ( Feely, J; Holden, RD; Johnston, GD; Radley, DR; Vyssoulis, G, 1995) |
| "The effects of a vasodilating beta-blocker, celiprolol, on insulin sensitivity and cardiovascular risk factors were compared with those of another beta1-selective adrenoceptor blocker, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors." | 5.08 | Insulin sensitivity in a long-term crossover trial with celiprolol and other antihypertensive agents. ( Ala-Kaila, K; Huupponen, R; Lahtela, J; Malminiemi, K; Malminiemi, O, 1998) |
| "The metabolic effects of celiprolol, a new beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity and alpha 2-blocking properties, were evaluated in a series of patients with hypertension, both with and without hyperlipidemia." | 5.06 | Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol. ( Cremoncini, M; Dujovne, CA; Gianfranceschi, G; Johnson, B; Montanari, G; Sirtori, CR; Sirtori, M; Vaccarino, V, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malminiemi, K | 4 |
| Lahtela, JT | 1 |
| Huupponen, R | 2 |
| Johnston, GD | 1 |
| Vyssoulis, G | 1 |
| Feely, J | 1 |
| Holden, RD | 1 |
| Radley, DR | 1 |
| Lahtela, J | 1 |
| Malminiemi, O | 1 |
| Ala-Kaila, K | 1 |
| Sirtori, CR | 1 |
| Johnson, B | 1 |
| Vaccarino, V | 1 |
| Montanari, G | 1 |
| Cremoncini, M | 1 |
| Gianfranceschi, G | 1 |
| Sirtori, M | 1 |
| Dujovne, CA | 1 |
| Hitzenberger, G | 1 |
6 trials available for celiprolol and Hyperlipemia
| Article | Year |
|---|---|
Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
Topics: Adult; Blood Glucose; Blood Pressure; Celiprolol; Female; Glucose Clamp Technique; Glucose Tolerance | 1995 |
Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Glucose; Blood Pressure; Celiprolol; Dru | 1995 |
Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
Topics: Adult; Aged; Blood Pressure; Celiprolol; Double-Blind Method; Female; Fibrinogen; Heart Rate; Humans | 1995 |
Insulin sensitivity in a long-term crossover trial with celiprolol and other antihypertensive agents.
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Celiprolol; Cross-Over Studies; Double-Blind Me | 1998 |
Long-term celiprolol therapy lowers fasting plasma leptin levels. Celiprolol Multicenter Study Group.
Topics: Adrenergic beta-Antagonists; Celiprolol; Fasting; Female; Glucose Tolerance Test; Humans; Hyperlipid | 2000 |
Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Celiprolol; Cholesterol; Chromatography, High Pressure Liq | 1989 |
1 other study available for celiprolol and Hyperlipemia
| Article | Year |
|---|---|
The effects of the beta-adrenoceptor blocking agent, celiprolol, on blood lipids.
Topics: Adrenergic beta-Antagonists; Celiprolol; Humans; Hyperlipidemias; Lipoproteins; Metoprolol; Propanol | 1985 |